Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement

Journal of Thoracic Oncology

Volumn 2, Issue 12, 2007, Pages 1107-1111

  Sakao, Yukinori ^a   Miyamoto, Hideaki ^a   Oh, Shiaki ^a   Takahashi, Nobumasa ^a   Sakuraba, Motoki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Extended radical nodal dissection; Mediastinal lymph node; N2; N3

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL ARTICLE; FEMALE; HUMAN; INFORMED CONSENT; LUNG CANCER; LUNG LOBE; LUNG RESECTION; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; PATHOLOGY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

EID: 37349061021     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31815ba24e     Document Type: Article

References (21)

1. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-1723.
2. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardovasc Surg 1978;76:832-839.
3. Watanabe Y, Hayashi Y, Shimizu J, Oda M, Iwa T. Mediastinal nodal involvement and prognosis of non-small cell lung cancer. Chest 1991;100:422-428.
4. Ichinose Y, Kato H, Koike T, et al. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardovasc Surg 2001;122:803-808.
5. Marc R, Jalal A, Patrick B, et al. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg 2005;79:225-233.
6. Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000;18:2981-2989.
7. Hata E, Troidl H, Hasegawa T. In vivo untersuchungen der lymph drainage des bronchialsystems beim menschen mit der lympho-szintigraphie: eine neue diagnostische technik. In H Hammelmann, H Troidl (Eds.), Behandlung des Bronchhialkarzinoms. Stuttgart, Germany: Thieme, 1981.
8. Nohl-Oser HC. An investigation of the anatomy of the lymphatic drainage of the lungs shown by the lymphatic spread of bronchial carcinoma. Ann R Coll Surg Engl 1972;51:157-176.
9. Miyamoto H, Wang Z, Fukai R, et al. Complete resection via median sternotomy for non-small cell lung cancer in the right upper lobe. ANZ J Surg 2005;75:1049-1054.
10. Hermanek P, Sobin LH. UICC TNM Classification of Malignant Tumors, 4th Ed. Berlin, Germany: Splinger-Verlag, 1992.
11. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-1723.
12. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardovasc Surg 1978;76:832-839.
13. Kotoulas CS, Foroulis CN, Kostikas K, et al. Involvement of lymphatic metastatic spread in non-small cell lung cancer according to the primary cancer location. Lung Cancer 2004;44:183-191.
14. Mountain CF. Expanded possibilities for surgical treatment of lung cancer-survival in stage IIIa disease. Chest 1990;97:1045-1051.
15. Thomas L, Lawrence R, Ahmad S; The Lung Study Group. The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. J Clin Oncol 1988;6:9-17.
16. Sakao Y, Miyamoto H, Yamazaki A, et al. The impact prognostic significance of metastasis to the highest mediastinal lymph node metastasis in non-small cell lung cancer. Ann Thorac Surg 2006;81:292-297.
17. Lacasse Y, Bucher HC, Wrong E, et al. "Incomplete resection" in non-small cell lung cancer: need for a new definition. Ann Thorac Surg 1998;65:220-226.
18. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer. J Thorac Cardiovasc Surg 2004;127:1087-92.
19. Gupta NC, Tamim WJ, Graeber GG, Bishop HA, Hobbs GR. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001;120:521-527.
20. Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group. Ann Thorac Surg 1997;63:1441-1450.
21. Lee JD, Ginsberg RJ. Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy. Ann Thorac Surg 1996;62:338-341.